Representatives of the Philippine Cancer Center (PCC) came to Bicol Regional Hospital and Medical Center (BRHMC) on July 25, 2022 to conduct a site visit at the Bicol Cancer Center (BCC) to check on the state of affairs of the said specialty area and determine compliance with requirements for operating a cancer center. 

2 weeks before the scheduled visit, the PCC team sent a questionnaire that would be used by the BCC as a guide in presenting progress reports, and serve to streamline discussions.  Issues under consideration included the cancer registry, infrastructure, equipment, human resource, research, services, referral system, financial requirements of the BRHMC-BCC, and status of the ₱90M-cancer center building, which is currently under construction.

The PCC team composed of Dr. Melissa Sena of the Health Facility Development Bureau, Development Management Officer Ms. Danielle Imperio, Research Specialist Ms. Christine Alayon, and Admin Assistant Ms. Shiela Mae F. Labongray provided inputs for resolving identified gaps, and offered suggestions for the continual improvement of the BRHMC Cancer Center.

The PCC is entrusted with the responsibility of improving cancer care research and development, in the country, as determined by RA 11215 – An Act Institutionalizing A National Integrated Cancer Program.  Among their tasks is the ocular inspection of DOH hospitals designated as Specialty Centers for Cancer Care, to ensure efficient and equitable use of resources supporting more responsive health systems for cancer care.  The BRHMC has been identified by the DOH thru Department Order 2021-0001 as a basic comprehensive specialty center for cancer.

Follow-up on the progress of the BRHMC-BCC will be done during the meeting on licensing requirements and development plans, which the PCC will hold in Manila in September this year.